FOR ADDICTION TREATMENT CENTERS — PAIN MANAGEMENT CLINICS
DNA-tagged Urine Drug Testing (UDT): A novel method ensuring sample integrity
by eliminating the need for observed urine collection.
Advanced LC-MS/MS Definitive Screening offers the following benefits:
Increased Sensitivity: This leads to a longer detection window.
Minimal or No Cross-Reactivity: Ensures low or no interference between drugs.
Enhanced Coverage: Detects a broader range of drugs and metabolites.
Key Features:
DNA-Tagged UDT
Eliminate observed urine collection.
Fast and Accurate
24-48 hours turn-around time from receipt at lab
High sensitivity and specificity.
Comprehensive Reporting
An easy-to-read summary report presents key information at a glance
A detailed report outlines test results and inconsistencies.
Simple Electronic Order portal
A cloud-based portal simplifies order placement and test result viewing
Seamless EMR integration streamlines processes
Provides a customizable panel for facility needs
Broad Insurance Coverage
Request more information.
References
R. Gregg et al. Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG), Genetics in Medicine. 23, 1793 – 1806 (2021).